Heads Up: Check-Cap Ltd. (NASDAQ: CHEK) Just Hit Our Monday Watchlist—Here’s Why

Krypton Street Announces Check-Cap Ltd. (NASDAQ: CHEK) as Its  Next Potential Breakout Idea… Check-Cap Ltd. (NASDAQ: CHEK) Comes Backed By Several Potential Catalysts Including: Low Float With Big Moves: Check-Cap Ltd. (NASDAQ: CHEK) Has A Low Float Of Just 4.38M Shares, Which Could Set the Stage for Sharp Swings, Including An Approximate 406% Move In Less Than A Day. Strong Insider Ownership: Over 25% Of Check-Cap Ltd. (NASDAQ: CHEK) Shares Are Held By Insiders, Indicating Confidence In The Company's Long-Term Vision. Innovative Screening Technology: Check-Cap Ltd. (NASDAQ: CHEK) Is Developing C-Scan®, A Prep-Free, Capsule-Based Colorectal Cancer Screening System Positioned In A Rapidly Expanding Market Projected To Surpass $24B By 2032. Key Regulatory Approvals: The Company Has Secured IDE Approval For U.S. Pivotal Studies, CE Mark Approval In Europe, FDA Breakthrough Device Designation. Bullish Technical Indicators Flashing: Late Friday Night, 14 Bullish Indicators Were Triggered, Including Exponential & Simple Moving Averages. Unmet Demand In A Growing Industry: Traditional Colorectal Cancer Screening Methods Deter Many Patients, Creating A Strong Need For More Accessible, Patient-Friendly Alternatives Like C-Scan®. Still Under The Radar: Despite Strong Fundamentals And Bullish Technical Signals, Check-Cap Ltd. (NASDAQ: CHEK) Remains Largely Undiscovered, Until Now. Keep Reading to See Why Check-Cap Ltd. (NASDAQ: CHEK) is Topping Our Watchlist Tomorrow Morning… February 23, 2025 Dear Reader, The wait is over. As promised, we’re revealing the latest name on our watchlist—one that has all the right ingredients for those who track low float companies with strong catalysts. Introducing Check-Cap Ltd. (NASDAQ: CHEK). This under-the-radar medical technology company is working to redefine colorectal cancer screening with its innovative prep-free, capsule-based detection system—positioned in a rapidly growing market projected to surpass $24B by 2032, where early intervention can make all the difference. With a float of just 4.38M shares, a market cap under $4.6M, and insider ownership exceeding 25%, this is a name that has remained off most radars—but with recent bullish indicators, that might not be the case for long. Why Check-Cap Ltd. (NASDAQ: CHEK) Stands Out: ✔ Recent Market Recognition: On 12/23, 2024, (NASDAQ: CHEK) opened at $0.60 and reached $3.04, marking an approximate 406% move in less than one day, demonstrating how quickly momentum can shift. ✔ Low Float (4.38M Shares): A small float can amplify the potential for movement if demand begins to increase, making it a key factor to watch. ✔ Insider Ownership (25%+): When key stakeholders hold a significant percentage of shares, it can indicate long-term confidence in the company’s direction. ✔ Innovative Technology in a High-Demand Market: Colorectal cancer is the third most diagnosed cancer globally and one of the least prevented, with low screening compliance due to the invasiveness of traditional methods. Check-Cap’s C-Scan® system is designed to solve this issue with a prep-free, capsule-based screening alternative aimed at increasing early detection rates. ✔ Regulatory Milestones & Global Expansion: The company has achieved IDE approval for U.S. pivotal studies, CE Mark approval in Europe for commercial sales, FDA Breakthrough Device Designation, and is expanding its global supply chain to prepare for larger-scale distribution. With these factors in play, Check-Cap is a company that’s worth watching closely. Technical Momentum: 14 Bullish Indicators Triggered Late Friday Night Late Friday night, Check-Cap (NASDAQ: CHEK) triggered 14 key bullish indicators, signaling increased momentum and technical strength. Highlighted Signals Include: ✅ Exponential Moving Average (10-day) ✅ Simple Moving Average (10-day) ✅ Exponential Moving Average (20-day) ✅ Simple Moving Average (20-day) ✅ Exponential Moving Average (30-day) ✅ Simple Moving Average (30-day) ✅ Exponential Moving Average (50-day) ✅ Simple Moving Average (50-day) ✅ Exponential Moving Average (100-day) ✅ Simple Moving Average (100-day) ✅ Volume Weighted Moving Average (20-day) ✅ Momentum (10-day) ✅ MACD Level (12-day, 26-day) ✅ Ultimate Oscillator (7-day, 14-day, 28-day) With technical signals aligning alongside strong fundamentals, Check-Cap Ltd. (NASDAQ: CHEK) could have the potential for continued momentum. What Happens Next? Right now, Check-Cap Ltd. (NASDAQ: CHEK) remains under the radar—but history shows that when demand builds, it often does so quickly. By tomorrow morning, you’ll be one of the few who know the name. 7 Reasons Why Check-Cap Ltd. (NASDAQ: CHEK) is Topping Our Watchlist  Tomorrow Morning… 1️⃣ Low Float: Check-Cap Ltd. (NASDAQ: CHEK) has a low float of just 4.38M shares, which has previously led to sharp moves, including an approximate 406% move on 12/23/2024, from $0.60 to $3.04 in less than a day. 2️⃣ Strong Insider Ownership: With over 25% insider ownership, key stakeholders hold a significant position in the company, which can indicate confidence in Check-Cap Ltd. (NASDAQ: CHEK)’s long-term vision. 3️⃣ Innovative Screening Technology: Check-Cap Ltd. (NASDAQ: CHEK) is developing C-Scan®, a prep-free, capsule-based colorectal cancer screening system, positioned in a rapidly growing market projected to surpass $24B by 2032. 4️⃣ Key Regulatory Approvals: The company has secured IDE approval for U.S. pivotal studies, CE Mark approval in Europe, FDA Breakthrough Device Designation, and is expanding its global supply chain in preparation for larger-scale distribution. 5️⃣ Bullish Technical Indicators: Late Friday night, 14 Bullish Technical Indicators were triggered, including Exponential & Simple Moving Averages (10-day, 20-day, 30-day, 50-day, 100-day), Volume Weighted Moving Average (20-day), Momentum (10-day), MACD Level (12-day, 26-day), and Ultimate Oscillator (7-day, 14-day, 28-day). 6️⃣ Unmet Demand in a Growing Industry: The company operates in a high-demand industry where traditional colorectal cancer screening methods deter patients, creating an urgent need for more accessible, patient-friendly alternatives. 7️⃣ Still Under the Radar: Despite strong fundamentals and recent technical signals, Check-Cap Ltd. (NASDAQ: CHEK) remains largely undiscovered, with awareness still building as new developments unfold. Consider Adding Check-Cap Ltd. (NASDAQ: CHEK) to Your  Radar This Week… Some companies fly under the radar—but not for long. Check-Cap Ltd. (NASDAQ: CHEK) has all the hallmarks we look for when identifying our next potential breakout idea. With a low float of just 4.38M shares, insider ownership exceeding 25%, and a position in a $24B+ industry, it’s a company with factors worth noting. Adding to that, 14 Bullish Technical Indicators flashed late Friday night, signaling potential momentum ahead. When you combine that with regulatory milestones, growing market demand, and a unique approach to colorectal cancer screening, this is a name we’re keeping a close watch on. We’ll be watching (NASDAQ: CHEK) first thing Monday morning.  If you haven’t already, it may be worth a look tonight before the morning bell. Check-Cap Ltd. (NASDAQ: CHEK) will be on our screens bright and early—stay tuned for my morning update. Sincerely, Alex Ramsay Co-Founder / Managing Editor Krypton Street Newsletter KryptonStreet.com (“KryptonStreet” or “KS” ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KryptonStreet is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in.vest.ment advice, are not in.vest.ment advisors, and any profiles we mention are not suitable for all in.vest.ors. The owner of Media 1717 LLC owns and operates kryptonstreet . com (“KS”). From time to time, KS will publicly disseminate information about a company via website, email, SMS and other points of media. Please see important disclosure information here: kryptonstreet.com/disclaimer/ *Media 1717 LLC has not been compensated for the February 23rd and 24th, 2025's profile on (CHEK:US). Neither Media 1717 LLC, TD Media LLC and their member own shares of (CHEK:US).

Media 1717 LLC | 6586 W Atlantic Ave Unit #2086 | Delray Beach, FL 33446 US Unsubscribe | Update Profile | Constant Contact Data Notice